Biogen Inc. stock price

Today's NASDAQ:BIIB chart, history & news

Price:
259.00 USD
Change:
-10.85 (-4.02%)
Trade Buy
67% of retail CFD accounts lose money

Key stats

Price open
Previous close 269.85
Market cap 39.45B
Volume 2.36M
Day high
Day low
Year high 363.92
Year low 223.25
Year to date change 6.18%
P/E ratio 10.44
Company Profile
Fundamentals
Insider Information
News

About Biogen Inc.

At Biogen, mission is clear: company is pioneer in neuroscience. Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. One of the world's first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp. Today Biogen has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, commercializes biosimilars of advanced biologics and is focused on advancing research programs in multiple sclerosis and neuroimmunology, Alzheimer's disease and dementia, neuromuscular disorders, movement disorders, ophthalmology, neuropsychiatry, immunology, acute neurology and neuropathic pain.

Company information

Company name
Biogen Inc.
Exchange
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Employees
7,300
CEO
George Scangos
Address
225 Binney St, Cambridge, Massachusetts, 02142-1031
Country
United States
Contact information
17814642000
Website
https://www.biogen.com/